Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study

Abstract Background The goal of the proposed study was to validate a rapid, simple, an accurate, robust, and sensitive bioanalytical method for quantifying Meloxicam and Lornoxicam (as internal standard) in rabbit plasma. Result Limit of detection and limit of quantification for Meloxicam were found...

Full description

Bibliographic Details
Main Authors: Nitin Salunkhe, Namdeo Jadhav, Somnath Bhinge
Format: Article
Language:English
Published: SpringerOpen 2020-09-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://link.springer.com/article/10.1186/s43094-020-00069-3
id doaj-f383eb45d8d344d7929dc9503d78b736
record_format Article
spelling doaj-f383eb45d8d344d7929dc9503d78b7362020-11-25T03:57:43ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532020-09-016111210.1186/s43094-020-00069-3Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic studyNitin Salunkhe0Namdeo Jadhav1Somnath Bhinge2Department of Pharmaceutics, Bharati Vidyapeeth College of PharmacyDepartment of Pharmaceutics, Bharati Vidyapeeth College of PharmacyRajarambapu College of PharmacyAbstract Background The goal of the proposed study was to validate a rapid, simple, an accurate, robust, and sensitive bioanalytical method for quantifying Meloxicam and Lornoxicam (as internal standard) in rabbit plasma. Result Limit of detection and limit of quantification for Meloxicam were found to be 0.0081 and 0.1035 μg mL−1, respectively. The bioanalysis was continued according to standard guidelines and successfully used for bioavailability studies of meloxicam after single dose administration of pure drug and the formulation in rabbit plasma. Finally, obtained results proved its simplicity and an efficiency to be applied for the therapeutic drug monitoring and bioequivalence studies. Conclusion Therefore, the set RP-HPLC bioanalysis is simple, convenient, and acceptable to analyze meloxicam in bulk and pharmaceutical formulations in rabbit plasma. Graphical abstracthttp://link.springer.com/article/10.1186/s43094-020-00069-3BioanalysisMeloxicamLornoxicamValidationPharmacokinetic StudyRabbit Plasma
collection DOAJ
language English
format Article
sources DOAJ
author Nitin Salunkhe
Namdeo Jadhav
Somnath Bhinge
spellingShingle Nitin Salunkhe
Namdeo Jadhav
Somnath Bhinge
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
Future Journal of Pharmaceutical Sciences
Bioanalysis
Meloxicam
Lornoxicam
Validation
Pharmacokinetic Study
Rabbit Plasma
author_facet Nitin Salunkhe
Namdeo Jadhav
Somnath Bhinge
author_sort Nitin Salunkhe
title Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
title_short Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
title_full Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
title_fullStr Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
title_full_unstemmed Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
title_sort meloxicam quantification in rabbit plasma by rp-hplc: optimization and application to pharmacokinetic study
publisher SpringerOpen
series Future Journal of Pharmaceutical Sciences
issn 2314-7253
publishDate 2020-09-01
description Abstract Background The goal of the proposed study was to validate a rapid, simple, an accurate, robust, and sensitive bioanalytical method for quantifying Meloxicam and Lornoxicam (as internal standard) in rabbit plasma. Result Limit of detection and limit of quantification for Meloxicam were found to be 0.0081 and 0.1035 μg mL−1, respectively. The bioanalysis was continued according to standard guidelines and successfully used for bioavailability studies of meloxicam after single dose administration of pure drug and the formulation in rabbit plasma. Finally, obtained results proved its simplicity and an efficiency to be applied for the therapeutic drug monitoring and bioequivalence studies. Conclusion Therefore, the set RP-HPLC bioanalysis is simple, convenient, and acceptable to analyze meloxicam in bulk and pharmaceutical formulations in rabbit plasma. Graphical abstract
topic Bioanalysis
Meloxicam
Lornoxicam
Validation
Pharmacokinetic Study
Rabbit Plasma
url http://link.springer.com/article/10.1186/s43094-020-00069-3
work_keys_str_mv AT nitinsalunkhe meloxicamquantificationinrabbitplasmabyrphplcoptimizationandapplicationtopharmacokineticstudy
AT namdeojadhav meloxicamquantificationinrabbitplasmabyrphplcoptimizationandapplicationtopharmacokineticstudy
AT somnathbhinge meloxicamquantificationinrabbitplasmabyrphplcoptimizationandapplicationtopharmacokineticstudy
_version_ 1724459046415630336